Andrea Gallardo

It’s a privilege to take care of people’s hearts | CardioOncology 🇪🇸 #Echofirst Cardiologist 🇲🇽 Editor for @medscape @cardio_ciencias. SoMe for #EJPC

[Cardiotipss @cardiotipss]

Simposio internacional de Cardio-oncología
🗓️ Jueves 25 septiembre de 7:00-18:00 hrs
📍Centro Médico ABC campus observatorio
‼️GRATUITO
‼️ Modalidad híbrida
Regístrate aquí: 👇🏻
https://t.co/YKr6Ux9R63
@ABCcentromedico @andreagallardo

[European Society of Cardiology Journals @ESC_Journals]

Patients who choose hybrid cardiac telerehabilitation (hCTR) are generally younger, fitter, and have a better QoL and mental health at the start of hCTR compared with those enrolling in centre-based CR. ➡️ https://t.co/swnYZEGoqZ

@EJPCEiC @AboyansV @SilCastelletti @PeroneFrancesco @andreagallardo

[European Society of Cardiology Journals @ESC_Journals]

Social determinants of health are independently associated with all-cause, cardiovascular, and cancer mortality among cancer survivors but not among individuals without cancer. https://t.co/09i7oWcRTL

@EJPCEiC @AboyansV @SilCastelletti @PeroneFrancesco @andreagallardo

[European Society of Cardiology Journals @ESC_Journals]

In middle-aged adults, CRF and MVPA demonstrated an inverse association with CAC incidence, but did not mitigate the increased CV risk associated with CAC https://t.co/3XOTX3vu55

@EJPCEiC @AboyansV @SilCastelletti @PeroneFrancesco @andreagallardo #EJPC

[The Heart @ZHeart11768530]

🔴Physiological Principles of Exercise⤵️ #2024Review #OpenAccess

🔹https://t.co/dE6B7RnnSm
#Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular #MedTwitter #medical #medEd

[EJPC Editor-in-Chief @EJPCEiC]

Adding ECG abnormalities to CVD risk models for people with T2D improves prediction accuracy by up to 8%

A simple, low-cost test with a big impact on personalized care🫀https://t.co/DmieTJKdoQ @AboyansV @SilCastelletti @PeroneFrancesco @Savvashad @andreagallardo @escardio

[EJPC Editor-in-Chief @EJPCEiC]

Validation of an adapted ARC-HBR criteria highlights its utility in identifying PCI patients with cancer at high bleeding risk
https://t.co/QLib6FwHF6 @escardio @AboyansV @SilCastelletti @PeroneFrancesco @Savvashad @andreagallardo

[EJPC Editor-in-Chief @EJPCEiC]

Adults with higher levels of albuminuria within the low range (UACR <30 mg/g) and no major cardiovascular risk factors have higher risks of cardiovascular and all-cause mortality 🩺
https://t.co/lINEvgNBBh
@escardio @AboyansV @SilCastelletti @PeroneFrancesco @andreagallardo

[EJPC Editor-in-Chief @EJPCEiC]

The use of SGLT2i is associated with a decreased risk of adverse clinical outcomes among patients with HCM with concurrent diabetes on antidiabetic drugs https://t.co/57KtZ3Rwrn
@escardio @AboyansV @SilCastelletti @PeroneFrancesco @andreagallardo #cvprev

[European Society of Cardiology Journals @ESC_Journals]

Multiple treatments are required to treat HoFH and management requires an individualised approach, with consideration given to the efficacy, safety, tolerability, and accessibility of each treatment 🩺💊 https://t.co/fLjrRFc3ve

@EJPCEiC @AboyansV @SilCastelletti @peronefrancesco @EAPCPresident @andreagallardo #cvprev #EAPC_ESC #EJPC

[EJPC Editor-in-Chief @EJPCEiC]

Lipoprotein(a) is an independent predictor for long-term in-stent restenosis and should be considered in the evaluation of patients undergoing PCI.
https://t.co/4lUH5tnR2h
@escardio @AboyansV @SilCastelletti @PeroneFrancesco @andreagallardo #cvprev

[European Society of Cardiology Journals @ESC_Journals]

Results from the European observational SANTORINI study: lipid-lowering therapy use and achievement of risk-based lipid goals increased over 1-year follow-up particularly when combination LLT was used 💊🩺
https://t.co/zd1oXgWlX3

@EJPCEiC @AboyansV @SilCastelletti @peronefrancesco @EAPCPresident @andreagallardo #cvprev #EAPC_ESC #EJPC

[Andrea Gallardo @andreagallardo]

All the miracles I’ve seen
Too good to not believe

[Andrea Gallardo @andreagallardo]

Your playing small does not serve the world

[European Society of Cardiology Journals @ESC_Journals]

📚 Predictive value of 8-year blood pressure measures in intracerebral haemorrhage risk over 5 years:
✏️ 12 398 participants
✏️ cumulative BP exposure was positively associated with subsequent 5-year risk of ICH
✏️ The cumBP could improve the risk reclassification of the conventional 5-year ICH risk prediction model https://t.co/gnZfrgh2YJ

@EJPCEiC @EAPCPresident #EJPC #cvprev #CVD #EAPC_ESC

[EJPC Editor-in-Chief @EJPCEiC]

Join us at the EAPC Congress in Milan 🇮🇹 (April 3-5, 2025) for the latest in cardiovascular prevention! 🫀

📅 Abstract deadline: Nov 21, 2024
💰 Early registration: Feb 3, 2025
Don't miss it!
👉 https://t.co/KyFDC5o0Gm #EAPC2025 #cvprev

[Dr. AK 🇮🇳 @docakx]

Three dimensional depiction of electrocardiographic leads

[EJPC Editor-in-Chief @EJPCEiC]

🚨 Cardiovascular deaths are projected to rise by 73% by 2050, driven by modifiable risk factors.

Urgent preventive measures are critical to reduce the global health burden 🫀
https://t.co/tds35UiHbx @escardio @AboyansV @SilCastelletti @Savvashad @andreagallardo @PeroneFrancesco

[Andrea Gallardo @andreagallardo]

Cuando das el paso el puente aparece

[EJPC Editor-in-Chief @EJPCEiC]

🏃🏻‍♀️ Even in advanced chronic kidney disease, exercise can reduce cardiovascular risk and improve quality of life 🫀 Any activity is better than no activity! 🏋🏻🚵🏻

Tailored, multidisciplinary programs are key 💪🏻 https://t.co/GampD65kIp